Researchers devise a progression risk-based classification for patients with AWM
Credit: Dana-Farber Cancer Institute By analyzing data from hundreds of patients with asymptomatic Waldenström macroglobulinemia (AWM), researchers at Dana-Farber Cancer Institute have devised a risk...










